Plant-based natural products against multidrug-resistant cancers: mechanisms of apoptosis induction and cell cycle modulation with a focus on breast cancer
- 6 November 2026
- journal article
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Chimie
- Vol. 29 (G1) , 669-707
Abstract
Breast cancer (BC) is a frequently diagnosed cancer in women worldwide and imposes a significant burden on healthcare systems. Although chemotherapy remains a primary treatment modality, its efficacy is often compromised by multidrug resistance (MDR), leading to poor clinical outcomes and treatment failure. Multidrug resistance in BC arises through multiple mechanisms, including decreased apoptotic activity, overexpression of ATP-binding cassette (ABC) transporters, alterations in the tumor microenvironment, enhanced DNA repair capacity, and epithelial–mesenchymal transition. Conventional chemotherapeutic agents such as doxorubicin and paclitaxel are effective against BC cells; however, their clinical utility is limited by MDR, severe side effects including cardiotoxicity and neuropathy, and reduced efficacy in resistant tumors. To address these challenges, natural products interfere with resistance mechanisms through diverse pathways, inhibiting efflux pumps such as P-glycoprotein, restoring apoptosis, and modulating signal transduction pathways, including PI3K/Akt and NF- κ B. Furthermore, they induce autophagy, inhibit unregulated cell growth, and modify the tumor microenvironment to enhance therapeutic response. Compounds such as curcumin, silybin, apigenin, berberine, matrine, and β -elemene have been shown to improve the effectiveness of chemotherapy, whether used as monotherapies or in combination with conventional drugs, while exhibiting minimal side effects compared to synthetic medicines. In conclusion, secondary metabolites derived from plants possess significant potential to overcome MDR in breast cancer. Their ability to attack resistance-related mechanisms through multiple pathways not only enhances the effectiveness of current therapy but also offers a promising source of safer and more effective anticancer agents.Keywords
This publication has 142 references indexed in Scilit:
- Reversal of cisplatin resistance by neferine/isoliensinine and their combinatorial regimens with cisplatin‐induced apoptosis in cisplatin‐resistant colon cancer stem cells (CSCs)Journal of Biochemical and Molecular Toxicology, 2021
- Autophagy and Tumour Chemotherapy2020
- Application of curcumin and its derivatives in tumor multidrug resistancePhytotherapy Research, 2020
- Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathwayPhytotherapy Research, 2020
- Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancerPhytotherapy Research, 2019
- Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell linesJournal of Cellular Physiology, 2018
- Rutin, a Quercetin Glycoside, Restores Chemosensitivity in Human Breast Cancer CellsPhytotherapy Research, 2017
- Apigenin Inhibits Cancer Stem Cell‐Like Phenotypes in Human Glioblastoma Cells via Suppression of c‐Met SignalingPhytotherapy Research, 2016
- Mechanisms of Multidrug Resistance in Cancer2009
- Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancerBreast Cancer Research and Treatment, 2008